University of Birmingham: Adding Antibody Treatment to Chemo Boosts Outcomes for Children With Rare Cancer
December 13, 2025
December 13, 2025
BIRMINGHAM, England, Dec. 13 (TNSjou) -- The University of Birmingham issued the following news:
* * *
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Phase two trial finds improved survival time among children who have neuroblastoma that comes back or doesn't respond to usual treatment
*
Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment o . . .
* * *
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Phase two trial finds improved survival time among children who have neuroblastoma that comes back or doesn't respond to usual treatment
*
Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment o . . .